ClinVar Miner

Submissions for variant NM_172056.2(KCNH2):c.472+1G>A (rs794728477)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000483249 SCV000567701 pathogenic not provided 2015-08-17 criteria provided, single submitter clinical testing Although the c.472+1 G>A variant has not been reported as a pathogenic variant or as a benign polymorphism to our knowledge, it has been reported in one other individual tested at GeneDx. This substitution destroys the canonical splice donor site in intron 3 and is predicted to cause abnormal gene splicing. The variant is predicted to lead to either an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. Other splice site variants in the KCNH2 gene have been reported in HGMD in association with LQTS (Stenson P et al., 2014). Furthermore, the c.472+1 G>A variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, c.472+1 G>A in the KCNH2 gene is interpreted as a pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.